On April 9, 2024, Biotricity, Inc. closed the transaction. The company announced that it has issued 110 shares of Series B Convertible Preferred Stock at an issue price of $9,090.91 per share for the gross proceeds of $1,000,000.1 in the second and final tranche. The minimum investment from an outsider is $1,000,000 and included participation from single investor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.09 USD | -11.02% | -9.17% | -5.22% |
Apr. 26 | Biotricity Inc. Announces High Demand for Its Latest Device, Biotres Pro | CI |
Apr. 19 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
-5.22% | 11.6M | |
-7.63% | 3.08B | |
-5.53% | 172M | |
-14.03% | 85.92M | |
-45.91% | 51.5M |
- Stock Market
- Equities
- BTCY Stock
- News Biotricity, Inc.
- Biotricity, Inc. announced that it has received $2 million in funding